CG
IONS icon

Cutler Group’s Ionis Pharmaceuticals IONS Stock Holding History

Cutler Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,200
Closed -$15K – 2902
2023
Q4 		$15K Buy
+10,200
New +$489K ﹤0.01% 2130
2022
Q2 		– Sell
-100
Closed -$1K – 5299
2022
Q1 		$1K Buy
+100
New +$3.27K ﹤0.01% 4993
2021
Q4 		– Sell
-7,400
Closed -$10K – 5695
2021
Q3 		$10K Buy
7,400
+2,400
+48% +$90.4K ﹤0.01% 3934
2021
Q2 		$1K Buy
+5,000
New +$196K ﹤0.01% 5312
2020
Q3 		– Sell
-1,000
Closed -$2K – 4949
2020
Q2 		$2K Hold
1,000
– – ﹤0.01% 3773
2020
Q1 		$1K Hold
1,000
– – ﹤0.01% 3718
2019
Q4 		$5K Hold
1,000
– – ﹤0.01% 3045
2019
Q3 		$6K Buy
+1,000
New +$65.2K ﹤0.01% 2919
2019
Q2 		– Sell
-4,000
Closed -$105K – 4508
2019
Q1 		$105K Sell
4,000
-11,700
-75% -$755K 0.01% 981
2018
Q4 		$30K Buy
15,700
+2,800
+22% +$143K ﹤0.01% 1810
2018
Q3 		$35K Sell
12,900
-900
-7% -$42.3K ﹤0.01% 1842
2018
Q2 		$18K Buy
13,800
+1,100
+9% +$48.8K ﹤0.01% 2260
2018
Q1 		$43K Sell
12,700
-14,300
-53% -$726K ﹤0.01% 1759
2017
Q4 		$263K Sell
27,000
-9,300
-26% -$510K 0.01% 817
2017
Q3 		$374K Sell
36,300
-18,100
-33% -$948K 0.01% 810
2017
Q2 		$501K Buy
54,400
+17,200
+46% +$801K 0.02% 695
2017
Q1 		$89K Sell
37,200
-32,100
-46% -$1.44M ﹤0.01% 1850
2016
Q4 		$370K Sell
69,300
-11,000
-14% -$435K 0.01% 879
2016
Q3 		$248K Buy
80,300
+19,400
+32% +$607K 0.01% 1043
2016
Q2 		$75K Buy
60,900
+17,900
+42% +$577K ﹤0.01% 1959
2016
Q1 		$39K Sell
43,000
-86,000
-67% -$3.49M ﹤0.01% 2581
2015
Q4 		$701K Buy
+129,000
New +$6.96M 0.04% 468

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's IONS Position: Q4 2022 in Review

Cutler Group sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 100 shares — an estimated $4K sold.

Cutler Group first reported a position in IONS in Q4 2015 and held it in 19 quarters. The position peaked at $3.43M in Q4 2015. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Cutler Group reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 100 Ionis Pharmaceuticals shares in Q4 2022, an estimated $4K.
  • Cutler Group first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • Cutler Group's Ionis Pharmaceuticals position peaked at $3.43M in Q4 2015.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.